Global Type-1 Diabetes Treatment Market Research Report 2024(Status and Outlook)
Report Overview:
Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes.
The Global Type-1 Diabetes Treatment Market Size was estimated at USD 5413.03 million in 2023 and is projected to reach USD 7049.17 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Type-1 Diabetes Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Type-1 Diabetes Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Type-1 Diabetes Treatment market in any manner.
Global Type-1 Diabetes Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.
Market Segmentation (by Type)
Rapid-Acting Insulin
Short-Acting Insulin
Others
Market Segmentation (by Application)
Hospitals & Clinics
Academic & Research Institutes
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Type-1 Diabetes Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes.
The Global Type-1 Diabetes Treatment Market Size was estimated at USD 5413.03 million in 2023 and is projected to reach USD 7049.17 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Type-1 Diabetes Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Type-1 Diabetes Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Type-1 Diabetes Treatment market in any manner.
Global Type-1 Diabetes Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.
Market Segmentation (by Type)
Rapid-Acting Insulin
Short-Acting Insulin
Others
Market Segmentation (by Application)
Hospitals & Clinics
Academic & Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Type-1 Diabetes Treatment Market
- Overview of the regional outlook of the Type-1 Diabetes Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Type-1 Diabetes Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Type-1 Diabetes Treatment
1.2 Key Market Segments
1.2.1 Type-1 Diabetes Treatment Segment by Type
1.2.2 Type-1 Diabetes Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TYPE-1 DIABETES TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Type-1 Diabetes Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Type-1 Diabetes Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TYPE-1 DIABETES TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Type-1 Diabetes Treatment Sales by Manufacturers (2019-2024)
3.2 Global Type-1 Diabetes Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Type-1 Diabetes Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Type-1 Diabetes Treatment Sales Sites, Area Served, Product Type
3.6 Type-1 Diabetes Treatment Market Competitive Situation and Trends
3.6.1 Type-1 Diabetes Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Type-1 Diabetes Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TYPE-1 DIABETES TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Type-1 Diabetes Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TYPE-1 DIABETES TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TYPE-1 DIABETES TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Type-1 Diabetes Treatment Sales Market Share by Type (2019-2024)
6.3 Global Type-1 Diabetes Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Type-1 Diabetes Treatment Price by Type (2019-2024)
7 TYPE-1 DIABETES TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Type-1 Diabetes Treatment Market Sales by Application (2019-2024)
7.3 Global Type-1 Diabetes Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2019-2024)
8 TYPE-1 DIABETES TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Type-1 Diabetes Treatment Sales by Region
8.1.1 Global Type-1 Diabetes Treatment Sales by Region
8.1.2 Global Type-1 Diabetes Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Type-1 Diabetes Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Type-1 Diabetes Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Type-1 Diabetes Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Type-1 Diabetes Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Type-1 Diabetes Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Astellas Pharma
9.1.1 Astellas Pharma Type-1 Diabetes Treatment Basic Information
9.1.2 Astellas Pharma Type-1 Diabetes Treatment Product Overview
9.1.3 Astellas Pharma Type-1 Diabetes Treatment Product Market Performance
9.1.4 Astellas Pharma Business Overview
9.1.5 Astellas Pharma Type-1 Diabetes Treatment SWOT Analysis
9.1.6 Astellas Pharma Recent Developments
9.2 Merck
9.2.1 Merck Type-1 Diabetes Treatment Basic Information
9.2.2 Merck Type-1 Diabetes Treatment Product Overview
9.2.3 Merck Type-1 Diabetes Treatment Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Type-1 Diabetes Treatment SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Type-1 Diabetes Treatment Basic Information
9.3.2 Eli Lilly Type-1 Diabetes Treatment Product Overview
9.3.3 Eli Lilly Type-1 Diabetes Treatment Product Market Performance
9.3.4 Eli Lilly Type-1 Diabetes Treatment SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Type-1 Diabetes Treatment Basic Information
9.4.2 Novo Nordisk Type-1 Diabetes Treatment Product Overview
9.4.3 Novo Nordisk Type-1 Diabetes Treatment Product Market Performance
9.4.4 Novo Nordisk Business Overview
9.4.5 Novo Nordisk Recent Developments
9.5 Sanofi
9.5.1 Sanofi Type-1 Diabetes Treatment Basic Information
9.5.2 Sanofi Type-1 Diabetes Treatment Product Overview
9.5.3 Sanofi Type-1 Diabetes Treatment Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Type-1 Diabetes Treatment Basic Information
9.6.2 AstraZeneca Type-1 Diabetes Treatment Product Overview
9.6.3 AstraZeneca Type-1 Diabetes Treatment Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Boehringer Ingelheim GmbH
9.7.1 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Basic Information
9.7.2 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Overview
9.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Market Performance
9.7.4 Boehringer Ingelheim GmbH Business Overview
9.7.5 Boehringer Ingelheim GmbH Recent Developments
9.8 Novartis
9.8.1 Novartis Type-1 Diabetes Treatment Basic Information
9.8.2 Novartis Type-1 Diabetes Treatment Product Overview
9.8.3 Novartis Type-1 Diabetes Treatment Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Type-1 Diabetes Treatment Basic Information
9.9.2 Pfizer Inc. Type-1 Diabetes Treatment Product Overview
9.9.3 Pfizer Inc. Type-1 Diabetes Treatment Product Market Performance
9.9.4 Pfizer Inc. Business Overview
9.9.5 Pfizer Inc. Recent Developments
9.10 Abbott Laboratories
9.10.1 Abbott Laboratories Type-1 Diabetes Treatment Basic Information
9.10.2 Abbott Laboratories Type-1 Diabetes Treatment Product Overview
9.10.3 Abbott Laboratories Type-1 Diabetes Treatment Product Market Performance
9.10.4 Abbott Laboratories Business Overview
9.10.5 Abbott Laboratories Recent Developments
9.11 Mannkind Corporation
9.11.1 Mannkind Corporation Type-1 Diabetes Treatment Basic Information
9.11.2 Mannkind Corporation Type-1 Diabetes Treatment Product Overview
9.11.3 Mannkind Corporation Type-1 Diabetes Treatment Product Market Performance
9.11.4 Mannkind Corporation Business Overview
9.11.5 Mannkind Corporation Recent Developments
9.12 Braun Melsungen AG
9.12.1 Braun Melsungen AG Type-1 Diabetes Treatment Basic Information
9.12.2 Braun Melsungen AG Type-1 Diabetes Treatment Product Overview
9.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Product Market Performance
9.12.4 Braun Melsungen AG Business Overview
9.12.5 Braun Melsungen AG Recent Developments
9.13 Macrogenics, Inc.
9.13.1 Macrogenics, Inc. Type-1 Diabetes Treatment Basic Information
9.13.2 Macrogenics, Inc. Type-1 Diabetes Treatment Product Overview
9.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Product Market Performance
9.13.4 Macrogenics, Inc. Business Overview
9.13.5 Macrogenics, Inc. Recent Developments
10 TYPE-1 DIABETES TREATMENT MARKET FORECAST BY REGION
10.1 Global Type-1 Diabetes Treatment Market Size Forecast
10.2 Global Type-1 Diabetes Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Type-1 Diabetes Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Type-1 Diabetes Treatment Market Size Forecast by Region
10.2.4 South America Type-1 Diabetes Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Type-1 Diabetes Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Type-1 Diabetes Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Type-1 Diabetes Treatment by Type (2025-2030)
11.1.2 Global Type-1 Diabetes Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Type-1 Diabetes Treatment by Type (2025-2030)
11.2 Global Type-1 Diabetes Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Type-1 Diabetes Treatment Sales (K Units) Forecast by Application
11.2.2 Global Type-1 Diabetes Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Type-1 Diabetes Treatment
1.2 Key Market Segments
1.2.1 Type-1 Diabetes Treatment Segment by Type
1.2.2 Type-1 Diabetes Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TYPE-1 DIABETES TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Type-1 Diabetes Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Type-1 Diabetes Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TYPE-1 DIABETES TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Type-1 Diabetes Treatment Sales by Manufacturers (2019-2024)
3.2 Global Type-1 Diabetes Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Type-1 Diabetes Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Type-1 Diabetes Treatment Sales Sites, Area Served, Product Type
3.6 Type-1 Diabetes Treatment Market Competitive Situation and Trends
3.6.1 Type-1 Diabetes Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Type-1 Diabetes Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TYPE-1 DIABETES TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Type-1 Diabetes Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TYPE-1 DIABETES TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TYPE-1 DIABETES TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Type-1 Diabetes Treatment Sales Market Share by Type (2019-2024)
6.3 Global Type-1 Diabetes Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Type-1 Diabetes Treatment Price by Type (2019-2024)
7 TYPE-1 DIABETES TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Type-1 Diabetes Treatment Market Sales by Application (2019-2024)
7.3 Global Type-1 Diabetes Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2019-2024)
8 TYPE-1 DIABETES TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Type-1 Diabetes Treatment Sales by Region
8.1.1 Global Type-1 Diabetes Treatment Sales by Region
8.1.2 Global Type-1 Diabetes Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Type-1 Diabetes Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Type-1 Diabetes Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Type-1 Diabetes Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Type-1 Diabetes Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Type-1 Diabetes Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Astellas Pharma
9.1.1 Astellas Pharma Type-1 Diabetes Treatment Basic Information
9.1.2 Astellas Pharma Type-1 Diabetes Treatment Product Overview
9.1.3 Astellas Pharma Type-1 Diabetes Treatment Product Market Performance
9.1.4 Astellas Pharma Business Overview
9.1.5 Astellas Pharma Type-1 Diabetes Treatment SWOT Analysis
9.1.6 Astellas Pharma Recent Developments
9.2 Merck
9.2.1 Merck Type-1 Diabetes Treatment Basic Information
9.2.2 Merck Type-1 Diabetes Treatment Product Overview
9.2.3 Merck Type-1 Diabetes Treatment Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Type-1 Diabetes Treatment SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Type-1 Diabetes Treatment Basic Information
9.3.2 Eli Lilly Type-1 Diabetes Treatment Product Overview
9.3.3 Eli Lilly Type-1 Diabetes Treatment Product Market Performance
9.3.4 Eli Lilly Type-1 Diabetes Treatment SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Type-1 Diabetes Treatment Basic Information
9.4.2 Novo Nordisk Type-1 Diabetes Treatment Product Overview
9.4.3 Novo Nordisk Type-1 Diabetes Treatment Product Market Performance
9.4.4 Novo Nordisk Business Overview
9.4.5 Novo Nordisk Recent Developments
9.5 Sanofi
9.5.1 Sanofi Type-1 Diabetes Treatment Basic Information
9.5.2 Sanofi Type-1 Diabetes Treatment Product Overview
9.5.3 Sanofi Type-1 Diabetes Treatment Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Type-1 Diabetes Treatment Basic Information
9.6.2 AstraZeneca Type-1 Diabetes Treatment Product Overview
9.6.3 AstraZeneca Type-1 Diabetes Treatment Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Boehringer Ingelheim GmbH
9.7.1 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Basic Information
9.7.2 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Overview
9.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Market Performance
9.7.4 Boehringer Ingelheim GmbH Business Overview
9.7.5 Boehringer Ingelheim GmbH Recent Developments
9.8 Novartis
9.8.1 Novartis Type-1 Diabetes Treatment Basic Information
9.8.2 Novartis Type-1 Diabetes Treatment Product Overview
9.8.3 Novartis Type-1 Diabetes Treatment Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Type-1 Diabetes Treatment Basic Information
9.9.2 Pfizer Inc. Type-1 Diabetes Treatment Product Overview
9.9.3 Pfizer Inc. Type-1 Diabetes Treatment Product Market Performance
9.9.4 Pfizer Inc. Business Overview
9.9.5 Pfizer Inc. Recent Developments
9.10 Abbott Laboratories
9.10.1 Abbott Laboratories Type-1 Diabetes Treatment Basic Information
9.10.2 Abbott Laboratories Type-1 Diabetes Treatment Product Overview
9.10.3 Abbott Laboratories Type-1 Diabetes Treatment Product Market Performance
9.10.4 Abbott Laboratories Business Overview
9.10.5 Abbott Laboratories Recent Developments
9.11 Mannkind Corporation
9.11.1 Mannkind Corporation Type-1 Diabetes Treatment Basic Information
9.11.2 Mannkind Corporation Type-1 Diabetes Treatment Product Overview
9.11.3 Mannkind Corporation Type-1 Diabetes Treatment Product Market Performance
9.11.4 Mannkind Corporation Business Overview
9.11.5 Mannkind Corporation Recent Developments
9.12 Braun Melsungen AG
9.12.1 Braun Melsungen AG Type-1 Diabetes Treatment Basic Information
9.12.2 Braun Melsungen AG Type-1 Diabetes Treatment Product Overview
9.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Product Market Performance
9.12.4 Braun Melsungen AG Business Overview
9.12.5 Braun Melsungen AG Recent Developments
9.13 Macrogenics, Inc.
9.13.1 Macrogenics, Inc. Type-1 Diabetes Treatment Basic Information
9.13.2 Macrogenics, Inc. Type-1 Diabetes Treatment Product Overview
9.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Product Market Performance
9.13.4 Macrogenics, Inc. Business Overview
9.13.5 Macrogenics, Inc. Recent Developments
10 TYPE-1 DIABETES TREATMENT MARKET FORECAST BY REGION
10.1 Global Type-1 Diabetes Treatment Market Size Forecast
10.2 Global Type-1 Diabetes Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Type-1 Diabetes Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Type-1 Diabetes Treatment Market Size Forecast by Region
10.2.4 South America Type-1 Diabetes Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Type-1 Diabetes Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Type-1 Diabetes Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Type-1 Diabetes Treatment by Type (2025-2030)
11.1.2 Global Type-1 Diabetes Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Type-1 Diabetes Treatment by Type (2025-2030)
11.2 Global Type-1 Diabetes Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Type-1 Diabetes Treatment Sales (K Units) Forecast by Application
11.2.2 Global Type-1 Diabetes Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Type-1 Diabetes Treatment Market Size Comparison by Region (M USD)
Table 5. Global Type-1 Diabetes Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Type-1 Diabetes Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Type-1 Diabetes Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Type-1 Diabetes Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
Table 10. Global Market Type-1 Diabetes Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Type-1 Diabetes Treatment Sales Sites and Area Served
Table 12. Manufacturers Type-1 Diabetes Treatment Product Type
Table 13. Global Type-1 Diabetes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Type-1 Diabetes Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Type-1 Diabetes Treatment Market Challenges
Table 22. Global Type-1 Diabetes Treatment Sales by Type (K Units)
Table 23. Global Type-1 Diabetes Treatment Market Size by Type (M USD)
Table 24. Global Type-1 Diabetes Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Type-1 Diabetes Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Type-1 Diabetes Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Type-1 Diabetes Treatment Market Size Share by Type (2019-2024)
Table 28. Global Type-1 Diabetes Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Type-1 Diabetes Treatment Sales (K Units) by Application
Table 30. Global Type-1 Diabetes Treatment Market Size by Application
Table 31. Global Type-1 Diabetes Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Type-1 Diabetes Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Type-1 Diabetes Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Type-1 Diabetes Treatment Market Share by Application (2019-2024)
Table 35. Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Type-1 Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Type-1 Diabetes Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Type-1 Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Type-1 Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Type-1 Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Type-1 Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Type-1 Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Astellas Pharma Type-1 Diabetes Treatment Basic Information
Table 44. Astellas Pharma Type-1 Diabetes Treatment Product Overview
Table 45. Astellas Pharma Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Astellas Pharma Business Overview
Table 47. Astellas Pharma Type-1 Diabetes Treatment SWOT Analysis
Table 48. Astellas Pharma Recent Developments
Table 49. Merck Type-1 Diabetes Treatment Basic Information
Table 50. Merck Type-1 Diabetes Treatment Product Overview
Table 51. Merck Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Type-1 Diabetes Treatment SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Eli Lilly Type-1 Diabetes Treatment Basic Information
Table 56. Eli Lilly Type-1 Diabetes Treatment Product Overview
Table 57. Eli Lilly Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Eli Lilly Type-1 Diabetes Treatment SWOT Analysis
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Recent Developments
Table 61. Novo Nordisk Type-1 Diabetes Treatment Basic Information
Table 62. Novo Nordisk Type-1 Diabetes Treatment Product Overview
Table 63. Novo Nordisk Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Recent Developments
Table 66. Sanofi Type-1 Diabetes Treatment Basic Information
Table 67. Sanofi Type-1 Diabetes Treatment Product Overview
Table 68. Sanofi Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. AstraZeneca Type-1 Diabetes Treatment Basic Information
Table 72. AstraZeneca Type-1 Diabetes Treatment Product Overview
Table 73. AstraZeneca Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Basic Information
Table 77. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Overview
Table 78. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Boehringer Ingelheim GmbH Business Overview
Table 80. Boehringer Ingelheim GmbH Recent Developments
Table 81. Novartis Type-1 Diabetes Treatment Basic Information
Table 82. Novartis Type-1 Diabetes Treatment Product Overview
Table 83. Novartis Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Novartis Business Overview
Table 85. Novartis Recent Developments
Table 86. Pfizer Inc. Type-1 Diabetes Treatment Basic Information
Table 87. Pfizer Inc. Type-1 Diabetes Treatment Product Overview
Table 88. Pfizer Inc. Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Inc. Business Overview
Table 90. Pfizer Inc. Recent Developments
Table 91. Abbott Laboratories Type-1 Diabetes Treatment Basic Information
Table 92. Abbott Laboratories Type-1 Diabetes Treatment Product Overview
Table 93. Abbott Laboratories Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Laboratories Business Overview
Table 95. Abbott Laboratories Recent Developments
Table 96. Mannkind Corporation Type-1 Diabetes Treatment Basic Information
Table 97. Mannkind Corporation Type-1 Diabetes Treatment Product Overview
Table 98. Mannkind Corporation Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Mannkind Corporation Business Overview
Table 100. Mannkind Corporation Recent Developments
Table 101. Braun Melsungen AG Type-1 Diabetes Treatment Basic Information
Table 102. Braun Melsungen AG Type-1 Diabetes Treatment Product Overview
Table 103. Braun Melsungen AG Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Braun Melsungen AG Business Overview
Table 105. Braun Melsungen AG Recent Developments
Table 106. Macrogenics, Inc. Type-1 Diabetes Treatment Basic Information
Table 107. Macrogenics, Inc. Type-1 Diabetes Treatment Product Overview
Table 108. Macrogenics, Inc. Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Macrogenics, Inc. Business Overview
Table 110. Macrogenics, Inc. Recent Developments
Table 111. Global Type-1 Diabetes Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Type-1 Diabetes Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Type-1 Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Type-1 Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Type-1 Diabetes Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Type-1 Diabetes Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Type-1 Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Type-1 Diabetes Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Type-1 Diabetes Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Type-1 Diabetes Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Type-1 Diabetes Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Type-1 Diabetes Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Type-1 Diabetes Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Type-1 Diabetes Treatment Market Size Comparison by Region (M USD)
Table 5. Global Type-1 Diabetes Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Type-1 Diabetes Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Type-1 Diabetes Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Type-1 Diabetes Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
Table 10. Global Market Type-1 Diabetes Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Type-1 Diabetes Treatment Sales Sites and Area Served
Table 12. Manufacturers Type-1 Diabetes Treatment Product Type
Table 13. Global Type-1 Diabetes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Type-1 Diabetes Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Type-1 Diabetes Treatment Market Challenges
Table 22. Global Type-1 Diabetes Treatment Sales by Type (K Units)
Table 23. Global Type-1 Diabetes Treatment Market Size by Type (M USD)
Table 24. Global Type-1 Diabetes Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Type-1 Diabetes Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Type-1 Diabetes Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Type-1 Diabetes Treatment Market Size Share by Type (2019-2024)
Table 28. Global Type-1 Diabetes Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Type-1 Diabetes Treatment Sales (K Units) by Application
Table 30. Global Type-1 Diabetes Treatment Market Size by Application
Table 31. Global Type-1 Diabetes Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Type-1 Diabetes Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Type-1 Diabetes Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Type-1 Diabetes Treatment Market Share by Application (2019-2024)
Table 35. Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Type-1 Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Type-1 Diabetes Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Type-1 Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Type-1 Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Type-1 Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Type-1 Diabetes Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Type-1 Diabetes Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Astellas Pharma Type-1 Diabetes Treatment Basic Information
Table 44. Astellas Pharma Type-1 Diabetes Treatment Product Overview
Table 45. Astellas Pharma Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Astellas Pharma Business Overview
Table 47. Astellas Pharma Type-1 Diabetes Treatment SWOT Analysis
Table 48. Astellas Pharma Recent Developments
Table 49. Merck Type-1 Diabetes Treatment Basic Information
Table 50. Merck Type-1 Diabetes Treatment Product Overview
Table 51. Merck Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Type-1 Diabetes Treatment SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Eli Lilly Type-1 Diabetes Treatment Basic Information
Table 56. Eli Lilly Type-1 Diabetes Treatment Product Overview
Table 57. Eli Lilly Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Eli Lilly Type-1 Diabetes Treatment SWOT Analysis
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Recent Developments
Table 61. Novo Nordisk Type-1 Diabetes Treatment Basic Information
Table 62. Novo Nordisk Type-1 Diabetes Treatment Product Overview
Table 63. Novo Nordisk Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Recent Developments
Table 66. Sanofi Type-1 Diabetes Treatment Basic Information
Table 67. Sanofi Type-1 Diabetes Treatment Product Overview
Table 68. Sanofi Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. AstraZeneca Type-1 Diabetes Treatment Basic Information
Table 72. AstraZeneca Type-1 Diabetes Treatment Product Overview
Table 73. AstraZeneca Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Basic Information
Table 77. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Overview
Table 78. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Boehringer Ingelheim GmbH Business Overview
Table 80. Boehringer Ingelheim GmbH Recent Developments
Table 81. Novartis Type-1 Diabetes Treatment Basic Information
Table 82. Novartis Type-1 Diabetes Treatment Product Overview
Table 83. Novartis Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Novartis Business Overview
Table 85. Novartis Recent Developments
Table 86. Pfizer Inc. Type-1 Diabetes Treatment Basic Information
Table 87. Pfizer Inc. Type-1 Diabetes Treatment Product Overview
Table 88. Pfizer Inc. Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Inc. Business Overview
Table 90. Pfizer Inc. Recent Developments
Table 91. Abbott Laboratories Type-1 Diabetes Treatment Basic Information
Table 92. Abbott Laboratories Type-1 Diabetes Treatment Product Overview
Table 93. Abbott Laboratories Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Abbott Laboratories Business Overview
Table 95. Abbott Laboratories Recent Developments
Table 96. Mannkind Corporation Type-1 Diabetes Treatment Basic Information
Table 97. Mannkind Corporation Type-1 Diabetes Treatment Product Overview
Table 98. Mannkind Corporation Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Mannkind Corporation Business Overview
Table 100. Mannkind Corporation Recent Developments
Table 101. Braun Melsungen AG Type-1 Diabetes Treatment Basic Information
Table 102. Braun Melsungen AG Type-1 Diabetes Treatment Product Overview
Table 103. Braun Melsungen AG Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Braun Melsungen AG Business Overview
Table 105. Braun Melsungen AG Recent Developments
Table 106. Macrogenics, Inc. Type-1 Diabetes Treatment Basic Information
Table 107. Macrogenics, Inc. Type-1 Diabetes Treatment Product Overview
Table 108. Macrogenics, Inc. Type-1 Diabetes Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Macrogenics, Inc. Business Overview
Table 110. Macrogenics, Inc. Recent Developments
Table 111. Global Type-1 Diabetes Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Type-1 Diabetes Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Type-1 Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Type-1 Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Type-1 Diabetes Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Type-1 Diabetes Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Type-1 Diabetes Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Type-1 Diabetes Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Type-1 Diabetes Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Type-1 Diabetes Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Type-1 Diabetes Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Type-1 Diabetes Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Type-1 Diabetes Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Type-1 Diabetes Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Type-1 Diabetes Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Type-1 Diabetes Treatment Market Size (M USD), 2019-2030
Figure 5. Global Type-1 Diabetes Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Type-1 Diabetes Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Type-1 Diabetes Treatment Market Size by Country (M USD)
Figure 11. Type-1 Diabetes Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Type-1 Diabetes Treatment Revenue Share by Manufacturers in 2023
Figure 13. Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Type-1 Diabetes Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Type-1 Diabetes Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Type-1 Diabetes Treatment Market Share by Type
Figure 18. Sales Market Share of Type-1 Diabetes Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Type-1 Diabetes Treatment by Type in 2023
Figure 20. Market Size Share of Type-1 Diabetes Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Type-1 Diabetes Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Type-1 Diabetes Treatment Market Share by Application
Figure 24. Global Type-1 Diabetes Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Type-1 Diabetes Treatment Sales Market Share by Application in 2023
Figure 26. Global Type-1 Diabetes Treatment Market Share by Application (2019-2024)
Figure 27. Global Type-1 Diabetes Treatment Market Share by Application in 2023
Figure 28. Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Type-1 Diabetes Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Type-1 Diabetes Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Type-1 Diabetes Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Type-1 Diabetes Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Type-1 Diabetes Treatment Sales Market Share by Country in 2023
Figure 37. Germany Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Type-1 Diabetes Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Type-1 Diabetes Treatment Sales Market Share by Region in 2023
Figure 44. China Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Type-1 Diabetes Treatment Sales and Growth Rate (K Units)
Figure 50. South America Type-1 Diabetes Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Type-1 Diabetes Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Type-1 Diabetes Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Type-1 Diabetes Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Type-1 Diabetes Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Type-1 Diabetes Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Type-1 Diabetes Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Type-1 Diabetes Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Type-1 Diabetes Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Type-1 Diabetes Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Type-1 Diabetes Treatment Market Size (M USD), 2019-2030
Figure 5. Global Type-1 Diabetes Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Type-1 Diabetes Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Type-1 Diabetes Treatment Market Size by Country (M USD)
Figure 11. Type-1 Diabetes Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Type-1 Diabetes Treatment Revenue Share by Manufacturers in 2023
Figure 13. Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Type-1 Diabetes Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Type-1 Diabetes Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Type-1 Diabetes Treatment Market Share by Type
Figure 18. Sales Market Share of Type-1 Diabetes Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Type-1 Diabetes Treatment by Type in 2023
Figure 20. Market Size Share of Type-1 Diabetes Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Type-1 Diabetes Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Type-1 Diabetes Treatment Market Share by Application
Figure 24. Global Type-1 Diabetes Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Type-1 Diabetes Treatment Sales Market Share by Application in 2023
Figure 26. Global Type-1 Diabetes Treatment Market Share by Application (2019-2024)
Figure 27. Global Type-1 Diabetes Treatment Market Share by Application in 2023
Figure 28. Global Type-1 Diabetes Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Type-1 Diabetes Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Type-1 Diabetes Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Type-1 Diabetes Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Type-1 Diabetes Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Type-1 Diabetes Treatment Sales Market Share by Country in 2023
Figure 37. Germany Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Type-1 Diabetes Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Type-1 Diabetes Treatment Sales Market Share by Region in 2023
Figure 44. China Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Type-1 Diabetes Treatment Sales and Growth Rate (K Units)
Figure 50. South America Type-1 Diabetes Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Type-1 Diabetes Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Type-1 Diabetes Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Type-1 Diabetes Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Type-1 Diabetes Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Type-1 Diabetes Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Type-1 Diabetes Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Type-1 Diabetes Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Type-1 Diabetes Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Type-1 Diabetes Treatment Market Share Forecast by Application (2025-2030)
